The Oncology Institute, Inc.TOIIWNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank78
Year-over-Year Change
Year-over-year operating income growth rate
Percentile
P78
Within normal range
vs 2Y Ago
4.2x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 28.16% |
| Q2 2025 | -13.12% |
| Q1 2025 | 16.92% |
| Q4 2024 | 13.89% |
| Q3 2024 | 15.34% |
| Q2 2024 | 8.95% |
| Q1 2024 | -17.56% |
| Q4 2023 | -9.79% |
| Q3 2023 | 6.78% |
| Q2 2023 | 54.55% |
| Q1 2023 | -31.05% |
| Q4 2022 | -24.79% |
| Q3 2022 | -9.80% |
| Q2 2022 | 0.90% |
| Q1 2022 | 54.76% |
| Q4 2021 | -1793.00% |
| Q3 2021 | -93.28% |
| Q2 2021 | 36.34% |
| Q1 2021 | 64.82% |
| Q4 2020 | -600.62% |
| Q3 2020 | -609.04% |
| Q2 2020 | 105.29% |
| Q1 2020 | 0.00% |
| Q4 2018 | 0.00% |